Juul KV - Search Results

1

Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study.

Arima H, Oiso Y, Juul KV, Nørgaard JP. Arima H, et al. Among authors: juul kv. Endocr J. 2013;60(9):1085-94. doi: 10.1507/endocrj.ej13-0165. Epub 2013 Jun 28. Endocr J. 2013. PMID: 23811987 Free article. Clinical Trial.

2

Desmopressin duration of antidiuretic action in patients with central diabetes insipidus.

Juul KV, Bichet DG, Nørgaard JP. Juul KV, et al. Endocrine. 2011 Aug;40(1):67-74. doi: 10.1007/s12020-011-9492-z. Epub 2011 May 29. Endocrine. 2011. PMID: 21626284 Clinical Trial.

3

Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial.

Yamaguchi O, Nishizawa O, Juul KV, Nørgaard JP. Yamaguchi O, et al. Among authors: juul kv. BJU Int. 2013 Mar;111(3):474-84. doi: 10.1111/j.1464-410X.2012.11547.x. Epub 2012 Oct 9. BJU Int. 2013. PMID: 23046147 Clinical Trial.

4

Desmopressin as an adjuvant to opioids or NSAIDs in treatment of renal colic: a nationwide register-based study.

Juul KV, Schroeder MK, Rittig S, Nørgaard JP. Juul KV, et al. Pharmacoepidemiol Drug Saf. 2015 Nov;24(11):1155-60. doi: 10.1002/pds.3875. Epub 2015 Sep 9. Pharmacoepidemiol Drug Saf. 2015. PMID: 26349846

5

National Surveillance of Central Diabetes Insipidus (CDI) in Denmark: results from 5 years registration of 9309 prescriptions of desmopressin to 1285 CDI patients.

Juul KV, Schroeder M, Rittig S, Nørgaard JP. Juul KV, et al. J Clin Endocrinol Metab. 2014 Jun;99(6):2181-7. doi: 10.1210/jc.2013-4411. Epub 2014 Feb 14. J Clin Endocrinol Metab. 2014. PMID: 24527719

6

Gender difference in antidiuretic response to desmopressin.

Juul KV, Klein BM, Sandström R, Erichsen L, Nørgaard JP. Juul KV, et al. Am J Physiol Renal Physiol. 2011 May;300(5):F1116-22. doi: 10.1152/ajprenal.00741.2010. Epub 2011 Mar 2. Am J Physiol Renal Physiol. 2011. PMID: 21367921 Free article. Clinical Trial.

7

Long-term durability of the response to desmopressin in female and male nocturia patients.

Juul KV, Klein BM, Nørgaard JP. Juul KV, et al. Neurourol Urodyn. 2013 Apr;32(4):363-70. doi: 10.1002/nau.22306. Epub 2012 Sep 12. Neurourol Urodyn. 2013. PMID: 22972524 Review.

8

Desmopressin melt improves response and compliance compared with tablet in treatment of primary monosymptomatic nocturnal enuresis.

Juul KV, Van Herzeele C, De Bruyne P, Goble S, Walle JV, Nørgaard JP. Juul KV, et al. Eur J Pediatr. 2013 Sep;172(9):1235-42. doi: 10.1007/s00431-013-1992-9. Epub 2013 May 16. Eur J Pediatr. 2013. PMID: 23677249 Free PMC article. Clinical Trial.

9

Clinical review: Treatment of neurohypophyseal diabetes insipidus.

Oiso Y, Robertson GL, Nørgaard JP, Juul KV. Oiso Y, et al. Among authors: juul kv. J Clin Endocrinol Metab. 2013 Oct;98(10):3958-67. doi: 10.1210/jc.2013-2326. Epub 2013 Jul 24. J Clin Endocrinol Metab. 2013. PMID: 23884783

10

Delaying time to first nocturnal void may have beneficial effects on reducing blood glucose levels.

Juul KV, Jessen N, Bliwise DL, van der Meulen E, Nørgaard JP. Juul KV, et al. Endocrine. 2016 Sep;53(3):722-9. doi: 10.1007/s12020-016-0920-y. Epub 2016 Mar 22. Endocrine. 2016. PMID: 27003433

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page